Formulation and Characterization of Atenolol-β-Cyclodextrin Orally Disintegrating Tablets

Rani, Karina Citra and Parfati, Nani and ., Stephanie (2017) Formulation and Characterization of Atenolol-β-Cyclodextrin Orally Disintegrating Tablets. In: International Symposium on Natural Medicines, 24-25 August 2017, IPB International Convention Center, Bogor, Indonesia.

[img]
Preview
PDF
Formulation and characterization of atenolol_NaniParfati.pdf

Download (4Mb) | Preview

Abstract

Atenolol is a competitive beta (1) -selective adrenergic antagonists and has been widely used in hypertension therapy. Atenolol has a low solubility characteristic in water and gastric fluid. For poorly soluble orally administered drugs, the rate of absorption is often controlled by the rate of dissolution. In this study, the solubility of atenolol has been increased by inclusion complex using β-cyclodextrin made by several methods (physical mixture, kneading, and solvent evaporation). Evaluation and characterization of atenolol-β-cyclodextrin inclusion complex consists of drug content, dissolution study, Fourier Transformed Infrared analysis (FT-IR), Differential Scanning Calorimetry (DSC), X-ray Diffraction (XRD), and Scanning Electron Microscope (SEM). The results of the drug content analysis, dissolution test, and characterization showed that atenolol- β-cyclodextrin inclusion complex, which has been made by solvent evaporation method was the best composition. Therefore, a solvent evaporation method was chosen to prepare orally disintegrating tablets of atenolol-β-cyclodextrin using direct compression technique. Orally disintegrating tablets of atenolol-β-cyclodextrin were prepared using crospovidone as disintegrant. The results of pre-compression test and post-compression test revealed that orally disintegrating tablets of atenolol-β-cyclodextrin inclusion complex had good physicochemical characteristics and met quality requirements.

Item Type: Conference or Workshop Item (Speech)
Uncontrolled Keywords: atenolol, inclusion complex, β-cyclodextrin, orally disintegrating tablets.
Subjects: R Medicine > RZ Other systems of medicine
Divisions: Faculty of Pharmacy > Department of Pharmacy
Depositing User: KARINA CITRA RANI
Date Deposited: 26 Feb 2018 09:00
Last Modified: 08 Aug 2018 01:57
URI: http://repository.ubaya.ac.id/id/eprint/31727

Actions (login required)

View Item View Item